Sign In
Buy TXG
$47.27
-2.16 (-4.37%)
At Close: Jul 31, 2026
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
04:05pm, Thursday, 09'th Oct 2025
PLEASANTON, Calif. , Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ende
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
08:00am, Thursday, 09'th Oct 2025
SEATTLE--(BUSINESS WIRE)--Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent.
10x Genomics, Inc. (TXG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
02:14pm, Wednesday, 10'th Sep 2025
10x Genomics, Inc. (NASDAQ:TXG ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Serge Saxonov - Co-Founder, CEO & Director Conference Call
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
09:00am, Tuesday, 09'th Sep 2025
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow procedu
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
04:05pm, Wednesday, 27'th Aug 2025
PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate
2 Growth Stocks Cathie Wood Is Buying Non-Stop
10:26am, Thursday, 21'st Aug 2025
Cathie Wood is most known for her bold, tech-first investing.
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
09:00am, Tuesday, 19'th Aug 2025
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif. ,
5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions
08:45am, Monday, 11'th Aug 2025
Tsakos Energy Navigation, 10x Genomics, Pan American Silver, Wolverine World Wide, and Interface top an efficiency-driven stock screen.
10x Genomics, Inc. (TXG) Q2 2025 Earnings Call Transcript
04:13am, Saturday, 09'th Aug 2025
10x Genomics, Inc. (NASDAQ:TXG ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Adam S. Taich - CFO, Treasurer, Principal Financial Officer & Principal Accounting Offi
10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say
07:31pm, Thursday, 07'th Aug 2025
Although the revenue and EPS for 10x Genomics (TXG) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Stre
10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates
06:36pm, Thursday, 07'th Aug 2025
10x Genomics (TXG) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of a loss of $0.35 per share. This compares to a loss of $0.32 per share a year ago.
10x Genomics Reports Second Quarter 2025 Financial Results
04:05pm, Thursday, 07'th Aug 2025
PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30,
10x Genomics to Acquire Scale Biosciences
04:04pm, Thursday, 07'th Aug 2025
Acquisition Will Further Expand Chromium's Capabilities PLEASANTON, Calif. , Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announce
Torex Gold Reports Q2 2025 Results
06:00pm, Wednesday, 06'th Aug 2025
Solid operational momentum through the end of the quarter sets the Company up for a strong second half of the year (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Ne
10x Genomics (TXG) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 06'th Aug 2025
10x Genomics (TXG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
